Physician profile
Clarence Lin
NPI 1073824975
$21,501.37
in general payments reported to CMS, 2019-2025
13 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $5,814 · 2021: $3,164 · 2022: $4,583 · 2023: $3,790 · 2024: $3,678 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,633 · Food and Beverage: $1,973 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,632.82 |
| Food and Beverage | $1,973.14 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,678.29 | 2019-2023 | Da Vinci Surgical System, Davinci Xi |
| W. L. Gore & Associates, INC. | $8,369.98 | 2022-2025 | Gore Bio-A Tissue Reinforcement, Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Davol INC. | $783.24 | 2019-2022 | |
| Conmed Corporation | $270.27 | 2022-2023 | Airseal |
| Bard Peripheral Vascular, INC. | $118.15 | 2020 | |
| Integra Lifesciences Corporation | $53.79 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $47.80 | 2023-2025 | Monocryl, Pds, Vicryl |
| Cumberland Pharmaceuticals, INC. | $42.62 | 2024 | Caldolor |
| Acera Surgical, INC. | $37.59 | 2025 | Restrata Wound Matrix |
| Myriad Genetic Laboratories, INC. | $32.08 | 2024 | Myrisk |
| Molli Surgical (US) INC | $31.27 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $18.32 | 2019 | |
| Becton, Dickinson and Company | $17.97 | 2024 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clarence Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.